| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00240-016-0882-9 |
| P698 | PubMed publication ID | 27115405 |
| P50 | author | Yunping Qiu | Q47229874 |
| Zigui Chen | Q53357813 | ||
| Robert D Burk | Q56916578 | ||
| Kelvin P Davies | Q56999202 | ||
| P2093 | author name string | Ilir Agalliu | |
| Joshua M Stern | |||
| Irwin Kurland | |||
| Saman Moazami | |||
| P2860 | cites work | Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease | Q24601951 |
| Linking long-term dietary patterns with gut microbial enterotypes | Q24609914 | ||
| QIIME allows analysis of high-throughput community sequencing data | Q24616873 | ||
| Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa | Q24622141 | ||
| Artificial sweeteners induce glucose intolerance by altering the gut microbiota | Q27968228 | ||
| Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up | Q28296597 | ||
| Search and clustering orders of magnitude faster than BLAST | Q29547431 | ||
| UniFrac: a new phylogenetic method for comparing microbial communities | Q29547435 | ||
| Diet rapidly and reproducibly alters the human gut microbiome | Q29547454 | ||
| A metagenome-wide association study of gut microbiota in type 2 diabetes | Q29547726 | ||
| Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome | Q29616853 | ||
| Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation | Q29617796 | ||
| Conservative fragments in bacterial 16S rRNA genes and primer design for 16S ribosomal DNA amplicons in metagenomic studies | Q33509522 | ||
| History of kidney stones and the risk of coronary heart disease | Q33606216 | ||
| pplacer: linear time maximum-likelihood and Bayesian phylogenetic placement of sequences onto a fixed reference tree | Q33733643 | ||
| Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes | Q34120699 | ||
| Prevalence of kidney stones in the United States | Q34267948 | ||
| The cervical microbiome over 7 years and a comparison of methodologies for its characterization | Q34336237 | ||
| Gut metagenome in European women with normal, impaired and diabetic glucose control | Q34347521 | ||
| Kidney stones associate with increased risk for myocardial infarction | Q34455437 | ||
| Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030 | Q34487788 | ||
| From the gastrointestinal tract (GIT) to the kidneys: live bacterial cultures (probiotics) mediating reductions of uremic toxin levels via free radical signaling | Q37357860 | ||
| The association of cardiovascular disease and metabolic syndrome with nephrolithiasis | Q37977369 | ||
| Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations | Q38047594 | ||
| Diabetes, obesity and gut microbiota | Q38114548 | ||
| Gut Bacteria Products Prevent AKI Induced by Ischemia-Reperfusion. | Q38919866 | ||
| Propionic acid and butyric acid inhibit lipolysis and de novo lipogenesis and increase insulin-stimulated glucose uptake in primary rat adipocytes | Q41189607 | ||
| Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex | Q41895522 | ||
| Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria | Q43850214 | ||
| Kidney stones | Q74683540 | ||
| Nephrolithiasis is associated with an increased prevalence of cardiovascular disease | Q84740303 | ||
| Animal protein and the risk of kidney stones: a comparative metabolic study of animal protein sources | Q87274686 | ||
| P433 | issue | 5 | |
| P921 | main subject | microbiome | Q1330402 |
| P304 | page(s) | 399-407 | |
| P577 | publication date | 2016-04-26 | |
| P1433 | published in | Urolithiasis | Q27724667 |
| P1476 | title | Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers | |
| P478 | volume | 44 |
| Q49898264 | 16S rRNA gene sequencing reveals altered composition of gut microbiota in individuals with kidney stones |
| Q94545229 | Abundance, Functional, and Evolutionary Analysis of Oxalyl-Coenzyme A Decarboxylase in Human Microbiota |
| Q101410020 | Animal models of naturally occurring stone disease |
| Q90204698 | Antibiotic Use and Risk of Incident Kidney Stones in Female Nurses |
| Q89861538 | Calcium Oxalate Nephrolithiasis and Gut Microbiota: Not just a Gut-Kidney Axis. A Nutritional Perspective |
| Q64097701 | Defining Dysbiosis in Patients with Urolithiasis |
| Q55506559 | Dietary Influence on Body Fluid Acid-Base and Volume Balance: The Deleterious "Norm" Furthers and Cloaks Subclinical Pathophysiology. |
| Q64117453 | Encrustations on ureteral stents from patients without urinary tract infection reveal distinct urotypes and a low bacterial load |
| Q64121092 | Fecal transplant modifies urine chemistry risk factors for urinary stone disease |
| Q58571195 | Functional eubacteria species along with trans-domain gut inhabitants favour dysgenic diversity in oxalate stone disease |
| Q37314836 | Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures |
| Q91845019 | Immunity, microbiota and kidney disease |
| Q92302733 | Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis |
| Q61443091 | Microbiome Alteration in Type 2 Diabetes Mellitus Model of Zebrafish |
| Q60921713 | Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease |
| Q47096559 | Microbiota Diversification and Crash Induced by Dietary Oxalate in the Mammalian Herbivore Neotoma albigula |
| Q58117933 | Oral Antibiotic Exposure and Kidney Stone Disease |
| Q92366679 | Overexpression of miR‑30c‑5p reduces cellular cytotoxicity and inhibits the formation of kidney stones through ATG5 |
| Q93259088 | Precision medicine in renal stone-formers |
| Q89210011 | Stones: Gut microbiome is unique in kidney stone disease |
| Q96953943 | The Bladder is Not Sterile: an Update on the Urinary Microbiome |
| Q58127667 | The link between antibiotic exposure and kidney stone disease |
| Q97527221 | The microbiome in urological diseases |
| Q36193540 | The role of the microbiome in kidney stone formation |
| Q88380263 | Updates in the Metabolic Management of Calcium Stones |
Search more.